Prestige Consumer Healthcare (NYSE:PBH) Receives Hold (C) Rating from Weiss Ratings

Key Points

• Weiss Ratings has reaffirmed a "hold (C)" rating for Prestige Consumer Healthcare (NYSE:PBH), amidst mixed analyst opinions regarding the stock's performance.
• Currently, 4 analysts rate the stock as a Buy, while 2 assign a Hold rating and 1 rates it as Sell, resulting in an average price target of $94.80.
• Prestige Consumer Healthcare reported a net income decline with earnings per share of $0.95 for the last quarter, missing estimates by $0.06 and showing a 6.6% year-over-year revenue drop.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

A number of other research analysts also recently issued reports on the company. Zacks Research downgraded Prestige Consumer Healthcare from a "hold" rating to a "strong sell" rating in a report on Thursday, September 4th. Sidoti upgraded Prestige Consumer Healthcare from a "neutral" rating to a "buy" rating and set a $80.00 price objective for the company in a report on Wednesday, September 24th. Wall Street Zen downgraded Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Canaccord Genuity Group decreased their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a report on Friday, August 8th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare currently has an average rating of "Hold" and an average price target of $94.80.

Prestige Consumer Healthcare Stock Up 0.7%

Shares of Prestige Consumer Healthcare stock opened at $63.32 on Wednesday. Prestige Consumer Healthcare has a 1 year low of $61.28 and a 1 year high of $90.04. The business has a 50-day moving average of $65.75 and a two-hundred day moving average of $76.53. The company has a market capitalization of $3.12 billion, a P/E ratio of 14.86, a price-to-earnings-growth ratio of 1.99 and a beta of 0.44. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same quarter last year, the company earned $0.90 earnings per share. The firm's revenue was down 6.6% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities analysts predict that Prestige Consumer Healthcare will post 4.5 EPS for the current year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. GAMMA Investing LLC increased its stake in shares of Prestige Consumer Healthcare by 35.9% in the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company's stock valued at $162,000 after purchasing an additional 496 shares during the last quarter. KBC Group NV increased its stake in shares of Prestige Consumer Healthcare by 7.4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after purchasing an additional 151 shares during the last quarter. QRG Capital Management Inc. increased its stake in shares of Prestige Consumer Healthcare by 8.6% in the 1st quarter. QRG Capital Management Inc. now owns 5,971 shares of the company's stock valued at $513,000 after purchasing an additional 475 shares during the last quarter. Intech Investment Management LLC increased its stake in shares of Prestige Consumer Healthcare by 18.9% in the 1st quarter. Intech Investment Management LLC now owns 27,307 shares of the company's stock valued at $2,348,000 after purchasing an additional 4,343 shares during the last quarter. Finally, XTX Topco Ltd increased its stake in shares of Prestige Consumer Healthcare by 354.0% in the 1st quarter. XTX Topco Ltd now owns 22,778 shares of the company's stock valued at $1,958,000 after purchasing an additional 17,761 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.